Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
CVS adds 4 new board members in deal with Glenview
Glenview Capital CEO Larry Robbins on the deal for new CVS Health board seats
Larry Robbins, Glenview Capital Management CEO, joins CNBC's 'Squawk on the Street' to discuss his firm's four new seats on the board at CVS, how the company can recover after a long decline, and more.
CVS Adds Glenview’s Robbins to Board Under Activist Pressure
CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that’s been pressuring the company for change. Most Read from BloombergIn Cleveland,
CVS Health Adds Four Board Seats In Deal With Hedge Fund
CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.
20h
Wu wraps up effort to fill vacant storefronts
The Wu administration has wrapped up the third and final round of SPACE grants aimed at using $10 million in federal funds to ...
4d
Larry Robbins' Strategic Moves in Q3 2024: A Deep Dive into Tenet Healthcare's Significant Reduction
We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we ...
The Business Journals
19h
CVS continues executive leadership shakeup
Joyner took over last month after the CVS board removed Karen Lynch following several quarters of lackluster financial ...
1d
on MSN
Stock market today: Wall Street rises following last week's slide
In other dealings early Monday, U.S. benchmark crude oil added 35 cents to $67.37 per barrel in electronic trading on the New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
CVS
Glenview Capital
Feedback